IPAM
MRNA icon

ICICI Prudential Asset Management’s Moderna MRNA Stock Holding History

ICICI Prudential Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,018
Closed -$335K – 164
2024
Q3 		$335K Buy
5,018
+809
+19% +$74.3K 0.04% 150
2024
Q2 		$500K Buy
4,209
+405
+11% +$51.3K 0.06% 124
2024
Q1 		$405K Buy
3,804
+104
+3% +$10.5K 0.05% 137
2023
Q4 		$368K Buy
3,700
+314
+9% +$26.4K 0.04% 129
2023
Q3 		$350K Buy
3,386
+795
+31% +$88.7K 0.05% 126
2023
Q2 		$315K Buy
2,591
+118
+5% +$15.7K 0.04% 118
2023
Q1 		$380K Buy
2,473
+544
+28% +$89.7K 0.06% 100
2022
Q4 		$346K Buy
1,929
+493
+34% +$80.6K 0.05% 91
2022
Q3 		$170K Buy
1,436
+250
+21% +$37.9K 0.03% 104
2022
Q2 		$169K Buy
1,186
+28
+2% +$4K 0.03% 101
2022
Q1 		$203K Buy
1,158
+158
+16% +$26.6K 0.03% 95
2021
Q4 		$254K Buy
+1,000
New +$292K 0.03% 84

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

ICICI Prudential Asset Management's MRNA Position: Q4 2024 in Review

ICICI Prudential Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 5,018 shares — an estimated $335K sold.

ICICI Prudential Asset Management first reported a position in MRNA in Q4 2021 and held it in 12 quarters. The position peaked at $500K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • ICICI Prudential Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • ICICI Prudential Asset Management sold 5,018 Moderna shares in Q4 2024, an estimated $335K.
  • ICICI Prudential Asset Management first reported a position in Moderna in Q4 2021 and held it in 12 quarters.
  • ICICI Prudential Asset Management's Moderna position peaked at $500K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on ICICI Prudential Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.